Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | DPP4 | P27487 | 6/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2689161 | 0.76 | MAPT (0.47) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL14277156 | 0.76 | MAPT (0.47) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL29209659 | 0.74 | CDC42 (0.33) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL11405175 | 0.74 | CDC42 (0.33) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL17977068 | 0.74 | ACE (0.31) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL17491127 | 0.74 | PIK3CD (0.41) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| Ammonia Solution, Strong SCHEMBL28819769 | 0.72 | PIK3CD (0.40) | ACE | |
| SCHEMBL4102268 | 0.72 | KDM1A (0.45) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL18601635 | 0.72 | KDM1A (0.45) | CYP3A4TSHRTDP1MAPTAPEX1 | |
| SCHEMBL253915 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088698-A1 | WATER IN OIL EMULSION, METHOD FOR THE PRODUCTION THEREOF | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-12 | — | — | US | disclosed |
| CN-101490041-A | 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation | ASTRAZENECA AB (SE) | 2009-07-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088698-A1 | WATER IN OIL EMULSION, METHOD FOR THE PRODUCTION THEREOF | H1-0, H1-3, H1-2 | CYP3A4 3420/4885TSHR 2697/4885TDP1 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.